NCT03880721Unknown不适用
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
Chinese PLA General Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Specificity
研究概览
简要总结
Developing a radiomics model to predict the prognosis of patients with hepatocellular carcinoma after microwave ablation to provide advice for their treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 90 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with primary hepatocellular carcinoma in the department of interventional ultrasound, PLA general hospital, who accept MWA therapy for HCC
- •Inclusion criteria:
- •Primary hepatocellular
- •No other treatments ware performed before microwave ablation
- •Patient has been clinically diagnosed with HCC definitely, and have a definite operational indication
- •No extrahepatic manifestations and no evidence of vessel invasion and bile duct thrombi
排除标准
- •Exclusion criteria:
- •Non-primary hepatocellular carcinoma or hepatic metastases
- •Accept other treatment before microwave ablation
- •Extrahepatic metastasis, vessel invasion or bile duct thrombi
结局指标
主要结局
Specificity
时间窗: through study completion, an average of 2 year
diagnosis specificity of intelligent ultrasound analysis
AUC value
时间窗: through study completion, an average of 2 year
Utilizing area under curve to judge the accurency
Sensitivity
时间窗: through study completion, an average of 2 year
diagnosis sensitivity of intelligent ultrasound analysis
次要结局
未报告次要终点
研究者
Ping Liang
Prof.
Chinese PLA General Hospital
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Radiomics of Hepatocellular CarcinomaHepatocellular CarcinomaNCT02757846Chinese Academy of Sciences1,200
进行中（未招募）
不适用
Artificial Intelligence and Hepatocellular CarcinomaHCCNCT05637788Humanitas Clinical and Research Center535
已完成
不适用
The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder CancerRadiomicsImmunotherapyBladder CancerNCT06381895Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1,200
招募中
不适用
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabAdvanced Hepatocellular CarcinomaNCT05173298CHA University100
Unknown
不适用
Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver MetastasesRectal CancerLiver MetastasesColon CancerNCT04213222Peking University People's Hospital300